EC knowledge among women of reproductive age: 19.6% (DHS 2010-11)
Contraceptive Use: 40.5% (DHS 2010-11, ever use of a modern method among women of reproductive age)
Registered LNG-EC products:
- Postinor-2* - Available only with prescription
- Pregnon - Available only with prescription
- Revoke 1.5* - Available only with prescription
- Revoke 72* - Available only with prescription
Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.
Where at least one type of ECP is available: Public sector clinics, Private clinics, Social marketing programs (eg PSI, DKT, MSI and PSIA)
Age restrictions for accessing ECPs: No data available
Legal/regulatory documents in which EC is included: National FP Norms, Essential Medicines List
Other relevant information: Zimbabwe's Essential Medicines List includes instructions on the Yuzpe regimen of EC, using combined oral contraceptives.
In Zimbabwe, the lowest cadre of health workers allowed to sell/dispense ECPs in the public sector is nurses. The lowest cadre of health workers allowed to sell/dispense ECPs in the private sector is nurses. (Data as of 2013.) (USAID/DELIVER, Contraceptive Security Indicators, 2013)
In 2013, EC was procured by the government. No stock-outs were reported at the central level (JSI/Deliver data).